Eyenuk Welcomes Paul Praino as Chief Commercial Officer
16. Februar 2023 08:00 ET
|
Eyenuk, Inc.
LOS ANGELES, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screening™ and AI Predictive...
Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma
31. Januar 2023 07:00 ET
|
Eyenuk, Inc.
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screening™ and AI Predictive...
UK National Screening Committee Report Singles Out Eyenuk’s EyeArt as the Only Diabetic Eye Screening AI Technology Ready for Live Clinical Implementation in the National Health Service
01. Juni 2022 03:05 ET
|
Eyenuk, Inc.
LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Joins the Population Health Alliance, Paving Way for Autonomous AI to Improve Diabetes Complications
10. März 2022 08:00 ET
|
Eyenuk, Inc.
WASHINGTON, March 10, 2022 (GLOBE NEWSWIRE) -- Population Health Alliance (PHA), the industry’s only multi-stakeholder professional and trade association solely focused on population health,...
Eyenuk Launches EyeArt AI System in South Africa in Collaboration with Discovery Health
07. Dezember 2021 10:36 ET
|
Eyenuk, Inc.
LOS ANGELES, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results in JAMA Network Open
15. November 2021 14:38 ET
|
Eyenuk, Inc.
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Applauds CMS CY 2022 Medicare Physician Fee Schedule Final Rule to Establish National Price for Autonomous AI Technology
04. November 2021 17:09 ET
|
Eyenuk, Inc.
LOS ANGELES, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk AI Technology Selected for Diabetic Eye Testing in Vietnam Supported by The Fred Hollows Foundation
26. Juli 2021 09:00 ET
|
Eyenuk, Inc.
LOS ANGELES, July 26, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy
20. Juli 2021 08:00 ET
|
Eyenuk, Inc.
LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Eyenuk Reports Strong 2021 Business Growth
12. Mai 2021 11:00 ET
|
Eyenuk, Inc.
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...